contraindications to glp 1 agonists Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review | Drugs Independent Nurse - GLP-1 and

- **Slow digestion:** Delaying stomach emptying to prevent spikes in sugar levels after meals

Online health startup Ro is getting into weight loss medicine, offering patients the trending obesity and diabetes GLP-1 class of drugs and real-time tracking.

Evidence-based insights for patients and providers.

While their glycemic, weight-lowering, and cardiovascular benefits are well established through randomized trials and meta-analyses, concerns remain regarding their safety and tolerability across diverse populations and clinical settings

Recent signals underscore this shift: Eli Lilly became the first pharmaceutical company to surpass a $1 trillion market capitalization [1] buoyed by global demand for obesity medications

Clostridium butyricum produces the postbiotic butyrate which stimulates GLP-1. Bifidobacterium infantis produces the postbiotic acetate, and interacts with Akkermansia and Butyricum to promote an ecosystem in the gut that naturally boosts GLP-1